New Drugs
« Previous EntriesRecent New Drug Applications
Tuesday, June 3rd, 2008Here are the most recent drug applications submitted to the FDA for approval. I always find it interesting to see what’s coming our way.
Sancuso (granisetron) Transdermal Patch Company: ProStrakan Group; Treatment for: Nausea/Vomiting - Chemotherapy Induced. Sancuso (granisetron) is an anti-emetic transdermal delivery system in development for the treatment of chemotherapy-induced nausea and vomiting without [...]
Cloretazine Shows Some Promising Results
Tuesday, June 3rd, 2008Vion Pharmaceuticals announced the interim data results of its pivotal phase II trial of cloretazine, an anticancer agent drug that is intended to treat elderly patients with de novo poor-risk acute myelogenous leukemia (AML) today. 35 percent of the 85 patients evaluated in the study responded to the drug treatment, and 90 percent of those [...]
Blogging About Alzheimers
Monday, June 2nd, 2008Patients diagnosed with early symptoms of Alzheimer’s disease are speaking out and demanding more attention, according to an article in today’s New York Times. Some patients - like 52-year-old Kris Bakowski of Athens, Ga. - are even blogging about their personal experience. Bakowski’s blog Creating Memories documents her daily struggles and successes with the disease.
There [...]
Baby Steps for Lung Cancer Patients
Monday, June 2nd, 2008I don’t want people to get the idea that I am opposed to prescription drugs and medicine. I firmly believe that there are drugs out there that have done wonders for the human race - and I think it’s amazing that there are people out there creating these wonder-meds… so I figure I should be [...]
May Drug Approvals
Monday, June 2nd, 2008So, just to keep up with my occasional updates on FDA drug approvals, I feel compelled to point out that May was a bumper month for new drugs - 166 approvals in total!
The list is way too long to go over in detail, but, wow. 166 new approvals in one month? If that is the [...]
FDA Approves Strattera
Friday, May 9th, 2008Eli Lilly and Company announced today that the FDA has approved Strattera for maintenance treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children and adolescents. Strattera, a selective norepinephrine reuptake inhibitor, is the first FDA-approved non-stimulant drug designed to treat ADHD in children, adolescents and adults.
Unlike other ADD and ADHD medications such as Adderall and Ritalin, which [...]
Blockbuster Cholesterol Drug A No-Go
Tuesday, April 29th, 2008The FDA denied approval of the much anticipated Merck & Co. cholesterol drug Cordaptive on Monday, stating that more information on the drug is needed, and that the trade name Cordaptive is not acceptable.
Merck is also the creator of the controversial cholesterol drug Vytorin, which came under fire in January when studies showed that the [...]
The End of An Arranged Marriage
Monday, April 28th, 2008Schering-Plough and Merck have been making moves to bring their two respective allergy drugs — Claritin and and Singulair — together to form one super-drug, but it according to a recent Wall Street Journal article, it doesn’t look like that is going to happen. On April 25, the company said late the FDA had rejected [...]
What Happens When A Pill Does Its Job A Little Too Well
Wednesday, April 23rd, 2008It looks like yet another miracle pill may be falling by the wayside. An April 23 AP article said it appears that a drug hat scientists had originally hoped would help people kick addictions and lose weight, might actually lead to increased risk of depression and suicide. It seems that the drug - which blocks [...]
The New Kids on the Block
Monday, April 21st, 2008I decided to do some research and find out the names of some of the latest drugs to arrive on the scene in so far this month. Here’s what I discovered (courtesy of Drugs.com):
Treximet, formerly Trexima, is sumatriptan succinate and naproxen sodium. It is being developed as a novel combination of sumatriptan succinate and naproxen [...]
« Previous Entries